pimagedine has been researched along with Ischemic Attack, Transient in 12 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danielisova, V | 1 |
| Burda, J | 1 |
| Nemethova, M | 1 |
| Gottlieb, M | 1 |
| Jackman, KA | 1 |
| Brait, VH | 1 |
| Wang, Y | 1 |
| Maghzal, GJ | 1 |
| Ball, HJ | 1 |
| McKenzie, G | 1 |
| De Silva, TM | 1 |
| Stocker, R | 1 |
| Sobey, CG | 1 |
| Zhu, DY | 1 |
| Deng, Q | 1 |
| Yao, HH | 1 |
| Wang, DC | 1 |
| Deng, Y | 1 |
| Liu, GQ | 1 |
| Park, EM | 1 |
| Cho, S | 1 |
| Frys, KA | 1 |
| Glickstein, SB | 1 |
| Zhou, P | 2 |
| Anrather, J | 2 |
| Ross, ME | 3 |
| Iadecola, C | 4 |
| Dingman, A | 1 |
| Lee, SY | 1 |
| Derugin, N | 1 |
| Wendland, MF | 1 |
| Vexler, ZS | 1 |
| Vakili, A | 2 |
| Hosseinzadeh, F | 1 |
| Sadogh, T | 1 |
| Zahedi-Khorasani, M | 1 |
| Kunz, A | 1 |
| Abe, T | 1 |
| Hochrainer, K | 1 |
| Shimamura, M | 1 |
| Racchumi, G | 1 |
| Zimmerman, GA | 1 |
| Meistrell, M | 1 |
| Bloom, O | 1 |
| Cockroft, KM | 1 |
| Bianchi, M | 1 |
| Risucci, D | 1 |
| Broome, J | 1 |
| Farmer, P | 1 |
| Cerami, A | 1 |
| Vlassara, H | 1 |
| Zhang, F | 2 |
| Casey, RM | 1 |
| Casey, R | 1 |
| Clark, HB | 1 |
| Mori, K | 1 |
| Togashi, H | 1 |
| Ueno, KI | 1 |
| Matsumoto, M | 1 |
| Yoshioka, M | 1 |
12 other studies available for pimagedine and Ischemic Attack, Transient
| Article | Year |
|---|---|
Aminoguanidine administration ameliorates hippocampal damage after middle cerebral artery occlusion in rat.
Topics: Animals; Enzyme Inhibitors; Guanidines; Hippocampus; Infarction, Middle Cerebral Artery; Ischemic At | 2011 |
Vascular expression, activity and function of indoleamine 2,3-dioxygenase-1 following cerebral ischaemia-reperfusion in mice.
Topics: Animals; Arterioles; Cerebral Cortex; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Immunoh | 2011 |
Inducible nitric oxide synthase expression in the ischemic core and penumbra after transient focal cerebral ischemia in mice.
Topics: Animals; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Enzyme Inhibitors; Guanidines; | 2002 |
Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury.
Topics: Animals; Cerebral Infarction; Disease Models, Animal; Enzyme Inhibitors; Female; Gene Expression Reg | 2006 |
Aminoguanidine inhibits caspase-3 and calpain activation without affecting microglial activation following neonatal transient cerebral ischemia.
Topics: Animals; Animals, Newborn; Blotting, Western; Calpain; Caspase 3; Caspases; Cell Count; Cell Death; | 2006 |
Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Infarction; Cerebral Arteries; Coloring Agents; Dos | 2007 |
Effect of aminoguanidine on post-ischemic damage in rodent model of stroke.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Admini | 2008 |
Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.
Topics: Amino Acid Sequence; Animals; CD36 Antigens; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Encephal | 2008 |
Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine.
Topics: Animals; Cerebral Infarction; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Glycati | 1995 |
Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Base Sequence; Body Water; Brain; Brain Damage, Chro | 1996 |
Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia.
Topics: Animals; Base Sequence; Cerebral Infarction; Cerebrovascular Circulation; Endothelium, Vascular; Enz | 1996 |
Aminoguanidine prevented the impairment of learning behavior and hippocampal long-term potentiation following transient cerebral ischemia.
Topics: Animals; Behavior, Animal; Electroshock; Enzyme Inhibitors; Fear; Guanidines; Hippocampus; Ischemic | 2001 |